Laboratory Testing for Neurologic Disorders, an Issue of the Clinics in Laboratory Medicine

A Zara Herskovits

ISBN 10: 0323762689 / ISBN 13: 9780323762687

Published by Elsevier Health Sciences Jul 2020, 2020

About this Item

This item is printed on demand - it takes 3-4 days longer - Neuware -This issue of Clinics in Laboratory Medicine, guest edited by Dr. A. Zara Herskovits, will cover Laboratory Testing for Neurologic Disorders. This issue is one of four selected each year by our Editor-in-Chief, Dr. Milenko Jovan Tanasijevic. Topics discussed in this issue will include: molecular approach to diagnostic testing for children with developmental delay and congenital anomalies, proteopathic and seeding assays (such as RT-QUIC), genetic testing for ALS and FTD, Diagnostic and prognostic testing for Alzheimer's disease, confounds in the interpretation of paraneoplastic antibody panels, Review of neurologic disease sendout testing at an academic medical center, development of new diagnostic tests for neurologic disorders, assuring quality in laboratory testing for sendout reference tests, diagnostic testing for patients with spinal muscular atrophy, among others. 240 pp. Englisch.

Seller Inventory # 9780323762687

Bibliographic Details

• Title: Laboratory Testing for Neurologic Disorders, an Issue of the Clinics in Laboratory Medicine
• Publisher: Elsevier Health Sciences Jul 2020
• Publication Date: 2020
• Language: English
• ISBN 10: 0323762689
• ISBN 13: 9780323762687
• Binding: Buch
• Condition: Neu
• Dimensions: 238W x 159H x 16D millimeters 238 millimeters width by 159 millimeters height by 16 millimeters depth
• Weight: 360 grams

About this title

Synopsis

This issue of Clinics in Laboratory Medicine, guest edited by Dr. A. Zara Herskovits, will cover Laboratory Testing for Neurologic Disorders. This issue is one of four selected each year by our Editor-in-Chief, Dr. Milenko Jovan Tanasijevic. Topics discussed in this issue will include: molecular approach to diagnostic testing for children with developmental delay and congenital anomalies, proteopathic and seeding assays (such as RT-QUIC), genetic testing for ALS and FTD, Diagnostic and prognostic testing for Alzheimer’s disease, confounds in the interpretation of paraneoplastic antibody panels, Review of neurologic disease sendout testing at an academic medical center, development of new diagnostic tests for neurologic disorders, assuring quality in laboratory testing for sendout reference tests, diagnostic testing for patients with spinal muscular atrophy, among others.